Cargando…
When Science is Not Enough: A Framework Towards More Customer-Focused Drug Development
INTRODUCTION: The purpose of this study was to identify the key barriers to a customer-focused drug development process and develop a comprehensive framework to overcome them. METHODS: The paper draws on existing literature, both academic and practitioner, across a range of disciplines (innovation m...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504205/ https://www.ncbi.nlm.nih.gov/pubmed/28625003 http://dx.doi.org/10.1007/s12325-017-0567-y |
_version_ | 1783249239749427200 |
---|---|
author | Oraiopoulos, Nektarios Dunlop, William C. N. |
author_facet | Oraiopoulos, Nektarios Dunlop, William C. N. |
author_sort | Oraiopoulos, Nektarios |
collection | PubMed |
description | INTRODUCTION: The purpose of this study was to identify the key barriers to a customer-focused drug development process and develop a comprehensive framework to overcome them. METHODS: The paper draws on existing literature, both academic and practitioner, across a range of disciplines (innovation management, marketing, organizational behavior, behavioral economics, health economics, industry reports). On the basis of this extensive review, a conceptual framework is developed that offers concrete suggestions on how organizations can overcome the barriers and enable a more customer-focused development process. RESULTS: The barriers to collaboration are organized into three distinct categories (economic, behavioral, organizational), and within each category, a one-to-one mapping between barriers and solutions is developed. CONCLUSION: The framework is specifically designed with the objective of offering actionable and practical advice to executives who face these challenges in their organizations. The paper provides a unique theoretical contribution by synthesizing findings from several academic disciplines with concrete examples from the pharmaceutical industry. FUNDING: Mundipharma International Limited. |
format | Online Article Text |
id | pubmed-5504205 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-55042052017-07-25 When Science is Not Enough: A Framework Towards More Customer-Focused Drug Development Oraiopoulos, Nektarios Dunlop, William C. N. Adv Ther Review INTRODUCTION: The purpose of this study was to identify the key barriers to a customer-focused drug development process and develop a comprehensive framework to overcome them. METHODS: The paper draws on existing literature, both academic and practitioner, across a range of disciplines (innovation management, marketing, organizational behavior, behavioral economics, health economics, industry reports). On the basis of this extensive review, a conceptual framework is developed that offers concrete suggestions on how organizations can overcome the barriers and enable a more customer-focused development process. RESULTS: The barriers to collaboration are organized into three distinct categories (economic, behavioral, organizational), and within each category, a one-to-one mapping between barriers and solutions is developed. CONCLUSION: The framework is specifically designed with the objective of offering actionable and practical advice to executives who face these challenges in their organizations. The paper provides a unique theoretical contribution by synthesizing findings from several academic disciplines with concrete examples from the pharmaceutical industry. FUNDING: Mundipharma International Limited. Springer Healthcare 2017-06-17 2017 /pmc/articles/PMC5504205/ /pubmed/28625003 http://dx.doi.org/10.1007/s12325-017-0567-y Text en © The Author(s) 2017 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Review Oraiopoulos, Nektarios Dunlop, William C. N. When Science is Not Enough: A Framework Towards More Customer-Focused Drug Development |
title | When Science is Not Enough: A Framework Towards More Customer-Focused Drug Development |
title_full | When Science is Not Enough: A Framework Towards More Customer-Focused Drug Development |
title_fullStr | When Science is Not Enough: A Framework Towards More Customer-Focused Drug Development |
title_full_unstemmed | When Science is Not Enough: A Framework Towards More Customer-Focused Drug Development |
title_short | When Science is Not Enough: A Framework Towards More Customer-Focused Drug Development |
title_sort | when science is not enough: a framework towards more customer-focused drug development |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504205/ https://www.ncbi.nlm.nih.gov/pubmed/28625003 http://dx.doi.org/10.1007/s12325-017-0567-y |
work_keys_str_mv | AT oraiopoulosnektarios whenscienceisnotenoughaframeworktowardsmorecustomerfocuseddrugdevelopment AT dunlopwilliamcn whenscienceisnotenoughaframeworktowardsmorecustomerfocuseddrugdevelopment |